People: Eli Lilly and Co (LLY.N)
18 Sep 2017
Dr. Jan M. Lundberg Ph.D., is Executive Vice President - Science and Technology, President - Lilly Research Laboratories of the Company. He has a Ph.D. from Sweden's Karolinska Institute, where he was a professor in the department of pharmacology before moving to industry. Prior to Karolinska, he attended Gustavus Adolphus College in Minnesota and the University of Gothenburg in Sweden. He has been a member of the Swedish Medical Research Council and of the Advisory Board for Drug Approvals at the Swedish Medical Product Agency. In January 2003, he was appointed Honorary Doctor of Pharmacy at Uppsala University. During the last 10 years at AstraZeneca, as head of global discovery research, he was instrumental in delivering 150 drug candidates to the company's pipeline. He had a role in external activities, including in-licensing of projects and technologies, as well as acquisitions of biotech companies. His organization was with both small molecules and biologics. For the past seven years, he has been an executive vice president and member of the senior executive team, reporting to the CEO of AstraZeneca.
|Total Annual Compensation, USD||2,187,040|
|Restricted Stock Awards, USD||3,600,000|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||687,852|
|Fiscal Year Total, USD||6,474,900|